| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jeffrey A. Meckler | Chief Executive Officer | 2025-07-27 | 6,068 | $8.30 | $50.38kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dexcel Pharma Technologies Ltd | 241.83% | 4,234,897 | $11.22M | Insider |
| Michael James Newman | 78.14% | 1,368,356 | $3.63M | Insider |
| Glen R. Anderson | 74.48% | 1,304,318 | $3.46M | Insider |
| John W. Kozarich | 8.67% | 151,761 | $402.17k | Insider |
| Anthony J. Maddaluna | 3.06% | 53,570 | $141.96k | Insider |
| Nadav Navon | 1.11% | 19,456 | $51.56k | Insider |
| Virtu Financial LLC | 1.08% | 18,997 | $50.34k | Institution |
| Jeffrey A. Meckler | 0.76% | 13,312 | $35.28k | Insider |
| Gil Bianco | 0.57% | 10,000 | $26.50k | Insider |
| Issac Silberman | 0.23% | 4,000 | $10.60k | Insider |